Literature DB >> 1853966

Fluoxetine in autism.

R D Todd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1853966     DOI： 10.1176/ajp.148.8.1089b

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

1.  Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.

Authors:  C J McDougle; L E Kresch; D J Posey
Journal:  J Autism Dev Disord       Date:  2000-10

2.  Commentary on 'Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)'

Authors:  Angela M Reiersen; Benjamin Handen
Journal:  Evid Based Child Health       Date:  2011-07

3.  Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial.

Authors:  S H Fatemi; G M Realmuto; L Khan; P Thuras
Journal:  J Autism Dev Disord       Date:  1998-08

Review 4.  Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Authors:  Michael G Aman; Cristan A Farmer; Jill Hollway; L Eugene Arnold
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-10

5.  Rare Opportunities for Insights Into Serotonergic Contributions to Brain and Bowel Disorders: Studies of the SERT Ala56 Mouse.

Authors:  Samantha E Stilley; Randy D Blakely
Journal:  Front Cell Neurosci       Date:  2021-06-03       Impact factor: 5.505
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.